Skip to main content
SpringerLink
Log in

ASO Visual Abstract: Talimogene Laherparepvec (T-VEC) for Treatment of Advanced Locoregional Melanoma after Failure of Immunotherapy: An International Multi-institutional Experience

  • ASO Visual Abstract
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Funding

This paper was not funded.

Author information

Author notes

  1. James Sun MD

    Present address: Department of Surgery, University Hospitals Cleveland Medical Center, Cleveland, OH, USA

  2. Luke D. Rothermel MD

    Present address: Department of Surgery, Division of Surgical Oncology, University Hospitals Cleveland Medical Center, Cleveland, OH, USA

Authors and Affiliations

  1. Department of Cutaneous Oncology, Moffitt Cancer Center, Tampa, FL, USA

    Michael J. Carr MD, James Sun MD, Danielle DePalo MD, Luke D. Rothermel MD, Amod A. Sarnaik MD & Jonathan S. Zager MD

  2. Department of Endocrine and Oncologic Surgery, University of Pennsylvania, Philadelphia, PA, USA

    Yun Song MD, Richard J. Straker MD & Giorgos C. Karakousis MD

  3. Department of Surgical Oncology, Emory University, Atlanta, GA, USA

    Kristin Baecher MD, Michael C. Lowe MD & Keith A. Delman MD

  4. Division of Surgical Oncology and Endocrine Surgery, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA

    Raphael J. Louie MD & David W. Ollila MD

  5. Department of Surgical Oncology, Netherlands Cancer Institute – Antoni van Leeuwenhoek, Amsterdam, The Netherlands

    Emma H. A. Stahlie MD & Alexander C. J. van Akkooi MD, PhD

  6. Department of Surgical Oncology, Spectrum Health/Michigan State University College of Human Medicine, Grand Rapids, MI, USA

    G. Paul Wright MD

  7. Department of Biostatistics and Bioinformatics, Moffitt Cancer Center, Tampa, FL, USA

    Syeda Mahrukh Hussnain Naqvi MD, MPH & Youngchul Kim PhD

  8. Division of Hematology and Oncology, Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA

    Frances Collichio MD

  9. Department of Oncologic Sciences, University of South Florida Morsani College of Medicine, Tampa, FL, USA

    Jonathan S. Zager MD

Authors
  1. Michael J. Carr MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. James Sun MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Danielle DePalo MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Luke D. Rothermel MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Yun Song MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Richard J. Straker MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Kristin Baecher MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Raphael J. Louie MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Emma H. A. Stahlie MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. G. Paul Wright MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Syeda Mahrukh Hussnain Naqvi MD, MPH
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Youngchul Kim PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Amod A. Sarnaik MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. Giorgos C. Karakousis MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  15. Michael C. Lowe MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  16. Keith A. Delman MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  17. Alexander C. J. van Akkooi MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  18. David W. Ollila MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  19. Frances Collichio MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  20. Jonathan S. Zager MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jonathan S. Zager MD.

Ethics declarations

Disclosures

J.S. has received research funding from Amgen. A.v.A. receives advisory board and consultancy honoraria from Amgen, Bristol-Myers Squibb, Novartis, MSD-Merck, Merck-Pfizer, Sanofi, and 4SC, all paid to the institution. He has received research grants from Amgen, Bristol-Myers Squibb, and Novartis, all paid to the institution. F.C.’s institution receives research funding from Amgen, Merck, and Novartis, a portion of which supports her salary. J.S.Z has advisory board relationships with Merck speaker’s bureau for Pfizer and Sun Pharma. He also receives research funding from Amgen, Delcath Systems, Philogen, Provectus, and Novartis. He is also a member of the speaker’s bureau for Amgen and SunPharma. A.S. receives consulting fees and sponsored travel from Iovance Biotherapeutics Inc, consulting fees from Guidepoint and Defined Health Inc. Honorarium, and sponsored travel from Physicians’ Educational Resource, LLC. Patent royalties from methods to improve adoptive cell therapy using Tumor-infiltrating lymphocytes. None of the financial disclosures are related to this present work. The remaining authors have no relevant conflicts of interest to disclose.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Carr, M.J., Sun, J., DePalo, D. et al. ASO Visual Abstract: Talimogene Laherparepvec (T-VEC) for Treatment of Advanced Locoregional Melanoma after Failure of Immunotherapy: An International Multi-institutional Experience. Ann Surg Oncol 29, 804–805 (2022). https://doi.org/10.1245/s10434-021-11036-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-021-11036-4

Search

Navigation